Clinical trial · Interventional
Laparoscopic Sentinel Node Navigation Surgery for Gastric Cancer
NCT01441310CI-TRIAL-00025394SNNScompletedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
There are few reports on a dual dye and isotope approach using laparoscopy in gastric cancer sentinel node mapping. The aim of this study was to evaluate the feasibility of laparoscopic limited gastrectomy with sentinel basin(SB) dissection for gastric cancer using simultaneous indocyanine green (ICG) and 99mTc-antimony sulfur colloid (ASC) injections.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Laparoscopic sentinel node navigation surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Laparoscopic sentinel node navigation surgery
- description
- Laparoscopic sentinel node navigation surgery
- interventionNames
- Procedure: Laparoscopic sentinel node navigation surgery
Primary outcomes (1)
- measure
- 3 Year disease free survival
- timeFrame
- Postoperative 3 year
- description
- Recurrence evaluation by eddoscopy, computed tomography and Positron emission tomography if needed.
Secondary outcomes (1)
- measure
- Sentinel node detection rate, occurrence of complication ,Qualtity of life and remnant stomach function evaluation.
- timeFrame
- postoperative 1, 3, 6, 12 month
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Age 20-80 * Informed consent * No other malignancies * cT1N0 stage gastric cancers \< 4cm * no allergic history of isotope Exclusion Criteria: * Patients eligible for endoscopic submucosal dissection(ESD) with absolute indication
References
Publications (0)
Data not yet available
No reference posted for this study.